by Clinical Neuropsychologist | Friday, August 30, 2024 | Dementia
Abstract INTRODUCTION Cellular prion protein (PrPC) was implicated in amyloid beta (Aβ)-induced toxicity in Alzheimer’s disease (AD), but the precise molecular mechanisms involved in this process are unclear. METHODS Double transgenic mice were generated by...
by Clinical Neuropsychologist | Friday, August 30, 2024 | Dementia
Dementia, Volume 24, Issue 2, Page 235-248, February 2025. Dementia is a leading cause of disability, and as the population ages, there will be a greater need for friends and family to care for people with Dementia. Unfortunately, informal care for a person with...
by Clinical Neuropsychologist | Friday, August 30, 2024 | Dementia
Dementia, Volume 24, Issue 3, Page 353-367, April 2025. Primary progressive aphasia (PPA) is a neurodegenerative brain disorder characterized by declining language ability. It is a rare, often young-onset dementia with a devastating impact on the work and personal...
by Clinical Neuropsychologist | Friday, August 30, 2024 | Dementia
Abstract INTRODUCTION Blood-derived microRNAs (miRNAs) are potential candidates for detecting and preventing subclinical cognitive dysfunction. However, replication of previous findings and identification of novel miRNAs associated with cognitive domains, including...
by Clinical Neuropsychologist | Friday, August 30, 2024 | Dementia
Abstract INTRODUCTION Alzheimer’s disease (AD) disproportionately affects minoritized populations who remain underrepresented in AD trials. METHODS We partnered with local nursing community-based organizations to implement a culturally tailored educational...
